- Citations, last 5 years
- 153
- Works, last 5 years
- 22
- h-index
- 51
- Scientists listed
- 2
- Grants since 2016
- 14
Grants received
2019–2023 · research · R01
Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever
Sean M Amberg · Kineta (United States) · funded by National Institutes of Health
2019–2023 · research · R01
Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever
Sean M Amberg · Kineta (United States) · funded by National Institutes of Health
2019–2023 · research · R01
Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever
Sean M Amberg · Kineta (United States) · funded by National Institutes of Health
2019–2023 · research · R01
Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever
Sean M Amberg · Kineta (United States) · funded by National Institutes of Health
2019–2023 · research · R01
Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever
Sean M Amberg · Kineta (United States) · funded by National Institutes of Health
2018 · research · R43
Development of an alpha-conotoxin RgIA analog as a novel, non-opioid therapeutic for chronic neuropathic pain
Jose L Mercado · Kineta (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics
Peter Probst · Kineta (United States) · funded by National Institutes of Health
2018–2021 · research · R44
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics
Shawn Patrick Iadonato · Kineta (United States) · funded by National Institutes of Health
2018–2021 · research · R44
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics
Shawn Patrick Iadonato · Kineta (United States) · funded by National Institutes of Health
2016–2018 · research · R44
Development of novel isoflavone drugs as broad spectrum antivirals
Kristin M Bedard · Kineta (United States) · funded by National Institutes of Health
2016–2017 · research · R41
Therapeutic Potential of the Potassium Channel Inhibitor SHK-186 for Pediatric Lupus
Peter Probst · Kineta (United States) · funded by National Institutes of Health
2016–2018 · research · R44
Development of novel isoflavone drugs as broad spectrum antivirals
Kristin M Bedard · Kineta (United States) · funded by National Institutes of Health
2016–2019 · grant · Innovations
Development of a small molecule, broadspectrum arenavirus antiviral as a therapeutic for Lassa fever
Kineta (United States) · funded by Wellcome Trust
2016–2020 · grant · Translation Fund
Development of a small molecule, broad-spectrum arenavirus antiviral as a therapeutic for Lassa fever
Dr Sean M Amberg · Kineta (United States) · funded by Wellcome Trust